I can’t seem to download that from my phone. Perhaps later when I’m home. But was a very poorly designed acquisition. The benefits were lopsided to Travis Bird. Joe and the entire team had poor focus over the last few years as money tightened.

https://investorshangout.com/post/view?id=5962373

Here’s where money should have went:

https://investorshangout.com/post/view?id=5962379

And maybe they’d have preclinical data to publish, enough to satisfy the fda to move forward, and to get Bintai to open their wallet.

Jmho. Calls for the BOD by myself, Doc and many to take control of this situation falls on mostly deaf ears. So currently I’d like to see them all replaced lol. If you can’t lead- resign or be fired. And best of luck moving forward. Hopefully, we see something good happen.